ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,424 | -79.2% | 14,808 | -74.1% | 0.00% | – |
| Q2 2023 | $213,756 | -45.7% | 57,154 | -51.4% | 0.00% | – |
| Q1 2023 | $393,947 | +16.6% | 117,596 | +67.4% | 0.00% | – |
| Q4 2022 | $337,922 | +144.9% | 70,254 | +188.9% | 0.00% | – |
| Q3 2022 | $138,000 | +2.2% | 24,320 | +28.2% | 0.00% | – |
| Q2 2022 | $135,000 | -95.2% | 18,972 | -95.1% | 0.00% | – |
| Q1 2022 | $2,797,000 | -64.4% | 387,529 | -55.9% | 0.00% | -100.0% |
| Q4 2021 | $7,863,000 | +97.5% | 879,516 | +674.5% | 0.00% | +200.0% |
| Q3 2021 | $3,981,000 | +245.3% | 113,566 | +111.7% | 0.00% | – |
| Q2 2021 | $1,153,000 | – | 53,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |